dbo:abstract |
أميفوستين يعرف بسيتوبروتيكتيفي يستخدم مساعدا في العلاج الكيميائي للسرطان والعلاج الإشعاعي المتعلقة بعوامل العلاج الكيميائي المرتبطة بالحمض النووي (DNA-binding). يتم تسويقه من قبل مجموعة (Group Clinigen) تحت الاسم التجاري Ethyol. (ar) Amifostine (ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol. (en) Amifostin ist der Internationale Freiname für einen zytoprotektiv wirksamen Arzneistoff. (de) L'amifostine est un adjuvant cytoprotecteur utilisé en chimiothérapie du cancer impliquant des agents chimiothérapeutiques liant l'ADN. Portion de texte anglais à traduire en français Texte anglais à traduire :Amifostine is used therapeutically to reduce the incidence of neutropenia-related fever and infection induced by DNA-binding chemotherapeutic agents including (e.g. cyclophosphamide) and platinum-containing agents (e.g. ). It is also used to decrease the cumulative nephrotoxicity associated with platinum-containing agents. Amifostine is also indicated to reduce the incidence of xerostomia in patients undergoing radiotherapy for head and neck cancer. Amifostine is an organic thiophosphate which is dephosphorylated in vivo by to the active cytoprotective thiol metabolite. The selective protection of non-malignant tissues is believed to be due to higher alkaline phosphatase activity, higher pH, and vascular permeation of normal tissues. Traduire ce texte • Outils • (+) (fr) A amifostina (WR-2721) é um fármaco da classe das anfetaminas substituídas que age na citoproteção. É utilizado em pacientes com câncer com a finalidade de proteção dos tecidos sadios devido ao tratamento quimioterápico. (pt) |
dbo:casNumber |
112901-68-5 20537-88-6 |
dbo:chEBI |
2636 |
dbo:chEMBL |
1006 |
dbo:drugbank |
DB01143 |
dbo:fdaUniiCode |
ILA426L95O M487QF2F4V |
dbo:kegg |
C06819 |
dbo:pubchem |
2141 |
dbo:thumbnail |
wiki-commons:Special:FilePath/Amifostine.svg?width=300 |
dbo:wikiPageID |
1531588 (xsd:integer) |
dbo:wikiPageLength |
6023 (xsd:nonNegativeInteger) |
dbo:wikiPageRevisionID |
1069406192 (xsd:integer) |
dbo:wikiPageWikiLink |
dbr:Alkylating_antineoplastic_agent dbr:Hypocalcemia dbr:DNA dbr:DNA_repair dbr:In_vivo dbr:Intravenous_therapy dbc:Amines dbc:Prodrugs dbr:Anaphylaxis dbr:Saline_(medicine) dbr:Erythema_multiforme dbr:Erythroderma dbr:Nausea dbr:Cisplatin dbr:Free_radicals dbr:Lung_cancer dbr:Stevens–Johnson_syndrome dbr:Prodrug dbc:Chemotherapeutic_adjuvants dbr:Toxic_epidermal_necrolysis dbr:Alkaline_phosphatase dbr:Cyclophosphamide dbr:PH dbr:Diarrhea dbr:Vomiting dbr:Hypersensitivity dbr:Adverse_drug_reaction dbr:Chemotherapy dbr:Mannitol dbr:Radiotherapy dbr:Warburg_effect_(oncology) dbr:Nephrotoxicity dbr:Neutropenia dbr:Hiccups dbr:Thiol dbr:Xerostomia dbr:Aminothiol dbr:File:WR-1065_skeletal.svg |
dbp:atcPrefix |
V03 (en) |
dbp:atcSuffix |
AF05 (en) |
dbp:bioavailability |
complete (en) |
dbp:c |
5 (xsd:integer) |
dbp:casNumber |
20537 (xsd:integer) 112901 (xsd:integer) |
dbp:chebi |
2636 (xsd:integer) |
dbp:chembl |
1006 (xsd:integer) |
dbp:chemspiderid |
2056 (xsd:integer) |
dbp:drugbank |
DB01143 (en) |
dbp:eliminationHalfLife |
480.0 |
dbp:h |
15 (xsd:integer) |
dbp:index2Label |
anhydrous (en) |
dbp:iupacName |
2 (xsd:integer) |
dbp:kegg |
6819.0 |
dbp:legalUs |
Rx-only (en) |
dbp:n |
2 (xsd:integer) |
dbp:o |
3 (xsd:integer) |
dbp:p |
1 (xsd:integer) |
dbp:pregnancyUs |
C (en) |
dbp:pubchem |
2141 (xsd:integer) |
dbp:routesOfAdministration |
dbr:Intravenous_therapy |
dbp:s |
1 (xsd:integer) |
dbp:smiles |
O=PSCCNCCCN (en) |
dbp:stdinchi |
1 (xsd:integer) |
dbp:stdinchikey |
JKOQGQFVAUAYPM-UHFFFAOYSA-N (en) |
dbp:unii |
ILA426L95O (en) M487QF2F4V (en) |
dbp:verifiedrevid |
456687875 (xsd:integer) |
dbp:wikiPageUsesTemplate |
dbt:Drugbox dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Ebicite dbt:Fdacite dbt:Keggcite dbt:Stdinchicite dbt:Drugs.com dbt:Detoxifying_agents_for_antineoplastic_treatment |
dcterms:subject |
dbc:Amines dbc:Prodrugs dbc:Chemotherapeutic_adjuvants |
gold:hypernym |
dbr:Adjuvant |
rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatAmines yago:Abstraction100002137 yago:AliphaticCompound114601294 yago:Amine114739004 yago:Chemical114806838 yago:Compound114818238 yago:Material114580897 yago:Matter100020827 yago:MethaneSeries114951377 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Relation100031921 dbo:Drug yago:Substance100019613 umbel-rc:DrugProduct |
rdfs:comment |
أميفوستين يعرف بسيتوبروتيكتيفي يستخدم مساعدا في العلاج الكيميائي للسرطان والعلاج الإشعاعي المتعلقة بعوامل العلاج الكيميائي المرتبطة بالحمض النووي (DNA-binding). يتم تسويقه من قبل مجموعة (Group Clinigen) تحت الاسم التجاري Ethyol. (ar) Amifostine (ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol. (en) Amifostin ist der Internationale Freiname für einen zytoprotektiv wirksamen Arzneistoff. (de) A amifostina (WR-2721) é um fármaco da classe das anfetaminas substituídas que age na citoproteção. É utilizado em pacientes com câncer com a finalidade de proteção dos tecidos sadios devido ao tratamento quimioterápico. (pt) L'amifostine est un adjuvant cytoprotecteur utilisé en chimiothérapie du cancer impliquant des agents chimiothérapeutiques liant l'ADN. Portion de texte anglais à traduire en français Texte anglais à traduire :Amifostine is used therapeutically to reduce the incidence of neutropenia-related fever and infection induced by DNA-binding chemotherapeutic agents including (e.g. cyclophosphamide) and platinum-containing agents (e.g. ). It is also used to decrease the cumulative nephrotoxicity associated with platinum-containing agents. Amifostine is also indicated to reduce the incidence of xerostomia in patients undergoing radiotherapy for head and neck cancer. (fr) |
rdfs:label |
أميفوستين (ar) Amifostin (de) Amifostine (en) Amifostine (fr) Amifostina (pt) |
owl:sameAs |
freebase:Amifostine yago-res:Amifostine http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB01143 http://www4.wiwiss.fu-berlin.de/sider/resource/drugs/2141 wikidata:Amifostine dbpedia-ar:Amifostine http://azb.dbpedia.org/resource/آمیفوستین dbpedia-de:Amifostine dbpedia-fa:Amifostine dbpedia-fr:Amifostine http://or.dbpedia.org/resource/ଆମିଫୋଷ୍ଟାଇନ dbpedia-pt:Amifostine dbpedia-sh:Amifostine dbpedia-sr:Amifostine dbpedia-vi:Amifostine https://global.dbpedia.org/id/2NMAL |
prov:wasDerivedFrom |
wikipedia-en:Amifostine?oldid=1069406192&ns=0 |
foaf:depiction |
wiki-commons:Special:FilePath/Amifostine.svg wiki-commons:Special:FilePath/WR-1065_skeletal.svg |
foaf:isPrimaryTopicOf |
wikipedia-en:Amifostine |
is dbo:wikiPageRedirects of |
dbr:C5H15N2O3PS dbr:Ethyol dbr:ATC_code_V03AF05 dbr:ATCvet_code_QV03AF05 |
is dbo:wikiPageWikiLink of |
dbr:Pyridoxamine dbr:List_of_MeSH_codes_(D02) dbr:Index_of_oncology_articles dbr:Chemoprotective_agent dbr:Chemotherapy-induced_peripheral_neuropathy dbr:Cisplatin dbr:Thiophosphate dbr:Organothiophosphate dbr:Ototoxicity dbr:C5H15N2O3PS dbr:Head_and_neck_cancer dbr:Ethyol dbr:Ex-Rad dbr:ATC_code_V03AF05 dbr:ATCvet_code_QV03AF05 dbr:Armed_Forces_Radiobiology_Research_Institute dbr:ATC_code_V03 dbr:List_of_drugs:_Am dbr:Southern_Research |
is foaf:primaryTopic of |
wikipedia-en:Amifostine |